Mike Carroll

Hutchens said seasonality persists but has been muted outside the selling season, likely because of higher underlying demand.

Hutchens tied the raised occupancy guide to first-half evidence and gave a quarter-to-date read on the selling season.

Justin confirmed focus remains on acquisitions delivering low- to mid-teens IRRs. Development may come in the future but not a current focus.

Justin emphasized volume remains the primary focus at 87% U.S. occupancy. Acknowledged better pricing power at higher-occupied communities but occupancy is the priority.

Hutchens said 'high confidence' on $2.5B target with pipeline continuing to grow beyond current guidance.

Hutchens said consistently buying below replacement cost. Newer communities closer to replacement cost, older ones well below. Cafaro added rents still need to grow significantly to justify new construction.

Hutchens confirmed 50% incremental margin from 80-90% occupancy, then 70% above 90%. Additionally, RevPOR growth 2x higher in communities above 90% occupied vs rest of portfolio.

Hutchens described mostly routine refreshes (common areas, paint, furniture, lighting). One major project at Hallmark Chicago high-rise getting full readout. Minimal disruption expected.

Hutchens said June had 60bps sequential growth, July expected as good or better, with strong tour and move-in activity continuing through key selling season.

Hutchens said momentum increasing, not decreasing, with $3B closed mostly in last 6 months. Operator relationships remain a key competitive advantage for sourcing deals.

Hutchens cited 41 transitions in 2023 case study: 820bps occupancy growth, outperforming NIC markets by 480bps, 40% YoY NOI growth. Acknowledged some disruption possible.

Hutchens declined exact EBITDAR update but said the 45 transitioning communities are outperforming Brookdale's remaining lease assets, with five new operators highly engaged.

Cafaro deflected from naming competitors, instead emphasizing discipline in not overpaying and noting very few deals are lost when Ventas truly wants them.

Hutchens cited reasons for winning (highest bid, off-market relationships, platform trust) and noted losses typically reflect valuation disconnects, not capability gaps.

Marc walked through all 5 projects: 311 Arsenal (82K LOIs for advanced tech), 40 Sylvan (advanced tech potential), 3000 Minuteman (160K LOI for non-lab), 421 Park (condo/institutional/office), all with milestones coming early 2027.

Marc confirmed 2026 construction budget is well-controlled; any scope changes would primarily impact 2027 spending.

Joel described leasing as episodically driven by clinical and data milestones, cautioning against reading Q4 trends as fundamentally different from Q2.

Joel explained the decision was driven by NIH indirect cost limitations reducing institutional demand, making office the logical use for this iconic building with long-term anchor Boston institutional tenants.

Peter confirmed significant East Grand leasing but emphasized a meaningful portion was absolute new tenancy, not relocations. Hallie added the leasing was diverse across Cambridge, Research Triangle, Seattle, and San Francisco.

Marc clarified the footnote details the 1.2M sqft known vacates (mostly lab, with one advanced tech site in Greater Stanford). Peter confirmed the remaining 1.3M sqft is also mostly lab with some tech.

Joel said demand exists across most tenant sectors except government and institutions. Revenue-producing companies seek Class A; less capitalized companies look for second-gen or move-out space.

Joel pushed back that FDA impact varies enormously by stage, R-stage companies are less focused on approvals than those in clinical trials.

Joel differentiated concerns by tenant type: institutions focused on NIH, public biotechs on financing ability, ventures on exit paths. No tangible FDA delay evidence seen.

Joel acknowledged decision-making is slower across the board due to tariff uncertainty, tax bill timing, and Fed inaction, but maintained his positive view on demand.

Marc confirmed \.4B of the \.1B future land bank is turning off capitalization as they pause and evaluate whether to resume, sell, or hold.

Brinker said Healthpeak will focus on core markets where its platform adds value, with most deals now fee simple rather than loans; 'we're not here to make loans.'

Carroll asked whether tenants are making quicker decisions and whether larger tenants are willing to commit to longer build-outs. Brinker noted supply/demand fundamentals moving dramatically in their favor. Bohn confirmed bulk of pipeline still prefers move-in-ready space but larger tenants are open to shell space.

Moses said pipeline is 50/50 new vs renewal with uptick in new prospective tenants. Second-gen space in good condition could commence sooner than 12 months.

Brinker broke down pipeline: ~300K under LOI, roughly half in active proposal stage, balance in tours and early inquiries. Weighted toward second half of process.

Moses said quality varies. Brinker emphasized almost exclusively core submarkets on campuses. Bohn noted some tenants are successfully raising capital with fundraises announced yesterday.

Brinker explained tenants used bankruptcy or assignment for benefit of creditors to exit leases, with specific assets being purchased from the bankruptcy estate.

Brinker declined to quantify at-risk tenants but maintained the guidance range captures all potential outcomes from the credit monitoring.

Kelvin described phased land takedown at negotiated valuation, with first site within 6-12 months of entitlements. DOC gets upside share with no capital commitment.

Brinker clarified the Torrey Pines loan is passive at <$800/ft basis when rents are $75-80. Higher LTC loans in pipeline would offer higher returns.

Brinker noted options vary, some at market, some with promotes or warrants. All are in strategic submarkets DOC wants to own.

Chaudhri confirmed the equity fund is fully committed and the roughly 750 million debt fund is practically fully deployed.

Mitra drew a clear distinction between the data science platform (capital allocation, external partnerships) and WBS (operational, internal). PSA collaboration is purely on data science for investment decisions, not operations. Banks exploring branch location optimization.

Shankh confirmed pricing power and labor scaling should widen spread but flagged headwinds from utilities and real estate taxes as cash flows recover; noted Q4 FFO per share and cash flow per share growth in high twenties.

Nikhil confirmed Barchester and HC-One portfolios are very similar to current Welltower portfolio in both asset quality and metrics on a blended basis.

Burkart noted more commonality across properties than expected, with 8,000+ employees onboarded and platform effectiveness building on itself with more data.

Burkart directly confirmed expectations for continued margin expansion, with Welltower Business System enabling sustained revenue outpacing expenses.

Burkart confirmed multi-year rollout timeline, emphasizing quality of implementation for site employee experience and real-time actionable data benefits.

Letter said the power pipeline has doubled in two years and framed 10 gigawatts as a confident projection with upside beyond it.

Dan said it varies by customer and timing, noted focus on powered shell with some turnkey over time. Tim added cost of capital considerations drive migration decisions.

Caton said renewals can be signed well in advance anywhere from 3 to 12 months depending on size and complexity. New leases can also vary with some starting quickly on available space while others involve construction or buildout taking longer. Implication is that post-April 2 leasing slowdown may take 1-2 quarters to fully impact occupancy metrics.